| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 65.381 | 48.807 | 52.763 | 50.881 | - | 58.323 | 63.144 | 59.029 | 42.107 | 42.111 |
| Total Income - EUR | 65.901 | 48.808 | 52.857 | 50.946 | - | 58.323 | 63.144 | 59.591 | 42.107 | 42.111 |
| Total Expenses - EUR | 62.202 | 51.252 | 49.576 | 48.285 | - | 48.878 | 39.737 | 31.118 | 25.319 | 20.479 |
| Gross Profit/Loss - EUR | 3.698 | -2.443 | 3.281 | 2.661 | - | 9.445 | 23.406 | 28.473 | 16.788 | 21.632 |
| Net Profit/Loss - EUR | 1.735 | -2.932 | 2.121 | 1.975 | - | 8.896 | 22.775 | 27.980 | 16.367 | 21.211 |
| Employees | 3 | 2 | 2 | 2 | - | 1 | 1 | 1 | 0 | 1 |
Check the financial reports for the company - Brownian Labs Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 28.124 | 14.902 | 27.097 | 49.485 | - | 28.328 | 21.044 | 14.350 | 16.174 | 14.047 |
| Current Assets | 13.975 | 6.339 | 6.990 | 4.263 | - | 9.737 | 16.489 | 47.423 | 11.639 | 20.898 |
| Inventories | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | 6.954 | 507 | 4.820 | 1.110 | - | 737 | 5.290 | 32.520 | 9.066 | 7.104 |
| Cash | 7.021 | 5.831 | 2.169 | 3.153 | - | 9.000 | 11.200 | 14.903 | 2.573 | 13.794 |
| Shareholders Funds | -14.295 | -17.076 | -14.666 | -12.421 | - | 8.656 | 31.239 | 27.425 | 27.498 | 31.356 |
| Social Capital | 45 | 45 | 44 | 43 | - | 41 | 40 | 41 | 40 | 40 |
| Debts | 56.393 | 38.584 | 48.943 | 67.699 | - | 29.518 | 6.401 | 34.455 | 422 | 3.695 |
| Income in Advance | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8299 - 8299" | |||||||||
| CAEN Financial Year |
8299
|
|||||||||
Comments - Brownian Labs Srl